173 related articles for article (PubMed ID: 15937504)
21. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
22. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia.
Richard S; Fruchtman S; Scigliano E; Skerrett D; Najfeld V; Isola L
Bone Marrow Transplant; 2000 Dec; 26(11):1225-8. PubMed ID: 11149736
[TBL] [Abstract][Full Text] [Related]
23. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
24. Fulminant myocarditis after allogeneic bone marrow transplantation: successful cytomegalovirus therapy and mechanical circulatory support for bridge to recovery.
Kataoka K; Takahashi T; Iwata H; Hangaishi A; Kumano K; Kurokawa M
Biol Blood Marrow Transplant; 2010 Jan; 16(1):129-30. PubMed ID: 20053334
[No Abstract] [Full Text] [Related]
25. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation.
Figuera A; Tomás JF; Otero MJ; Moreno E; García I; Fernández-Rañada JM
Am J Hematol; 1996 May; 52(1):68-9. PubMed ID: 8638625
[No Abstract] [Full Text] [Related]
26. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
27. Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.
Locatelli F; Zecca M; Niemeyer C; Angelucci E; Arcese G; Bender-Gotze C; Bonetti F; Burdach S; Dini G; Ebell W; Friedrich W; Hasle H; Hermann J; Jacobsen N; Klingebiel T; Kremens B; Mann G; Miniero R; Pession A; Peters C; Paolucci P; Rossetti F; Schmid HJ; Stary J; Zimmermann M
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():63-8. PubMed ID: 8932802
[No Abstract] [Full Text] [Related]
28. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes.
George JN; Selby GB
Bone Marrow Transplant; 2004 Jun; 33(11):1073-4. PubMed ID: 15153944
[No Abstract] [Full Text] [Related]
30. T-cell-depleted stem cell boost for the treatment of autoimmune haemolytic anaemia after T-cell-depleted allogeneic bone marrow transplantation complicated by adenovirus infection.
Hilgendorf I; Wolff D; Wilhelm S; Steiner B; Kiefel V; Hickstein H; Junghanss C; Freund M; Casper J
Bone Marrow Transplant; 2006 May; 37(10):977-8. PubMed ID: 16565736
[No Abstract] [Full Text] [Related]
31. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
32. Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Remberger M; Ringdén O
Transplantation; 2007 Aug; 84(4):551-4. PubMed ID: 17713443
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH
Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516
[TBL] [Abstract][Full Text] [Related]
34. Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation.
Sugiyama A; Takeuchi S; Fukagawa S; Moroi Y; Yoshimoto G; Miyamoto T; Akashi K; Furue M
J Dermatol; 2012 Feb; 39(2):172-5. PubMed ID: 21951268
[TBL] [Abstract][Full Text] [Related]
35. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation.
Fassas AB; Buddharaju LN; Rapoport A; Cottler-Fox M; Drachenberg C; Meisenberg B; Tricot G
Leuk Lymphoma; 2001 Aug; 42(4):801-4. PubMed ID: 11697511
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Díaz-Heredia C; Badell I; Bureo E; Gómez P; Martínez A; Verdeguer A; Pérez-Hurtado JM; Fernández-Delgado R; González-Vicent M; Maldonado MS
Pediatr Hematol Oncol; 2009; 26(5):345-55. PubMed ID: 19579081
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.
Davies JK; Taussig DC; Oakervee H; Davies AJ; Agrawal SG; Gribben JG; Lister TA; Cavenagh JD
J Clin Oncol; 2006 May; 24(14):e23-5. PubMed ID: 16682729
[No Abstract] [Full Text] [Related]
38. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
[TBL] [Abstract][Full Text] [Related]
39. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y; Sakamaki H; Sao H; Okamoto S; Kodera Y; Tanosaki R; Kasai M; Hiraoka A; Takahashi S; Miyawaki S; Kawase T; Morishima Y; Kato S;
Biol Blood Marrow Transplant; 2005 Nov; 11(11):881-9. PubMed ID: 16275591
[TBL] [Abstract][Full Text] [Related]
40. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
Platzbecker U; von Bonin M; Goekkurt E; Radke J; Binder M; Kiani A; Stoehlmacher J; Schetelig J; Thiede C; Ehninger G; Bornhäuser M
Biol Blood Marrow Transplant; 2009 Jan; 15(1):101-8. PubMed ID: 19135948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
